SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $505,000 | -35.5% | 165,569 | -2.1% | 0.12% | -37.8% |
| Q3 2016 | $783,000 | -12.5% | 169,079 | +9.4% | 0.18% | -20.3% |
| Q2 2016 | $895,000 | +83.8% | 154,619 | +91.9% | 0.23% | +49.7% |
| Q1 2016 | $487,000 | -35.8% | 80,569 | +66.4% | 0.16% | -32.9% |
| Q1 2015 | $759,000 | +54.9% | 48,430 | +50.4% | 0.23% | +32.8% |
| Q4 2014 | $490,000 | +87.7% | 32,210 | +33.3% | 0.17% | +72.3% |
| Q3 2014 | $261,000 | – | 24,170 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |